These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32853128)

  • 1. Clinical pharmacology of cannabidiol in refractory epilepsy.
    Schaiquevich P; Riva N; Maldonado C; Vázquez M; Cáceres-Guido P
    Farm Hosp; 2020 Jun; 44(5):222-229. PubMed ID: 32853128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.
    Porcari GS; Fu C; Doll ED; Carter EG; Carson RP
    Epilepsy Behav; 2018 Mar; 80():240-246. PubMed ID: 29429908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures.
    Klein P; Tolbert D; Gidal BE
    Epilepsy Behav; 2019 Oct; 99():106459. PubMed ID: 31519475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy.
    Wheless JW; Dlugos D; Miller I; Oh DA; Parikh N; Phillips S; Renfroe JB; Roberts CM; Saeed I; Sparagana SP; Yu J; Cilio MR;
    CNS Drugs; 2019 Jun; 33(6):593-604. PubMed ID: 31049885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Efficacy of Cannabidiol in Subjects with Refractory Epilepsy Relative to Concomitant Use of Clobazam.
    Mandelbaum DE
    Epilepsy Res; 2022 Feb; 180():106285. PubMed ID: 32051101
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of cannabidiol in subjects with refractory epilepsy relative to concomitant use of clobazam.
    Savage TE; Sourbron J; Bruno PL; Skirvin LA; Wolper ES; Anagnos CJ; Thiele EA
    Epilepsy Res; 2020 Feb; 160():106263. PubMed ID: 31923763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy.
    Patel S; Grinspoon R; Fleming B; Skirvin LA; Wade C; Wolper E; Bruno PL; Thiele EA
    Epilepsia; 2021 Jul; 62(7):1594-1603. PubMed ID: 34050682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience.
    Chen KA; Farrar M; Cardamone M; Gill D; Smith R; Cowell CT; Truong L; Lawson JA
    Med J Aust; 2018 Aug; 209(5):217-221. PubMed ID: 30092753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme.
    Harte S; Singh Y; Malone S; Heussler H; Wallace G
    BMC Health Serv Res; 2022 Feb; 22(1):173. PubMed ID: 35144615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
    Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
    CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
    Hess EJ; Moody KA; Geffrey AL; Pollack SF; Skirvin LA; Bruno PL; Paolini JL; Thiele EA
    Epilepsia; 2016 Oct; 57(10):1617-1624. PubMed ID: 27696387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy.
    Birnbaum AK; Karanam A; Marino SE; Barkley CM; Remmel RP; Roslawski M; Gramling-Aden M; Leppik IE
    Epilepsia; 2019 Aug; 60(8):1586-1592. PubMed ID: 31247132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN; Szaflarski JP; Gidal B; VanLandingham K; Critchley D; Morrison G
    Epilepsia; 2020 Sep; 61(9):1854-1868. PubMed ID: 32918835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol as potential treatment in refractory pediatric epilepsy.
    Paolino MC; Ferretti A; Papetti L; Villa MP; Parisi P
    Expert Rev Neurother; 2016; 16(1):17-21. PubMed ID: 26567560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol for the treatment of refractory epilepsy in children: a critical review of the literature.
    Moreira GA; Moraes Neto R; Ribeiro RG; Crippa ACS
    Rev Paul Pediatr; 2022; 41():e2021197. PubMed ID: 35830160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerance of cannabidiol in the treatment of epilepsy in patients with Rett syndrome.
    Desnous B; Beretti T; Muller N; Neveu J; Villeneuve N; Lépine A; Daquin G; Milh M
    Epilepsia Open; 2024 Feb; 9(1):397-403. PubMed ID: 37485779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of cannabidiol prescribed for children with refractory epilepsy.
    Freeman JL
    Med J Aust; 2018 Aug; 209(5):228-229. PubMed ID: 30092751
    [No Abstract]   [Full Text] [Related]  

  • 18. Purified Cannabidiol for Treatment of Refractory Epilepsies in Pediatric Patients with Developmental and Epileptic Encephalopathy.
    Pietrafusa N; Ferretti A; Trivisano M; de Palma L; Calabrese C; Carfì Pavia G; Tondo I; Cappelletti S; Vigevano F; Specchio N
    Paediatr Drugs; 2019 Aug; 21(4):283-290. PubMed ID: 31179531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
    Devinsky O; Marsh E; Friedman D; Thiele E; Laux L; Sullivan J; Miller I; Flamini R; Wilfong A; Filloux F; Wong M; Tilton N; Bruno P; Bluvstein J; Hedlund J; Kamens R; Maclean J; Nangia S; Singhal NS; Wilson CA; Patel A; Cilio MR
    Lancet Neurol; 2016 Mar; 15(3):270-8. PubMed ID: 26724101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of cannabidiol with other antiseizure medications: A narrative review.
    Gilmartin CGS; Dowd Z; Parker APJ; Harijan P
    Seizure; 2021 Mar; 86():189-196. PubMed ID: 33541771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.